DFA
REGN icon

Delta Financial Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Delta Financial Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$881K Sell
1,413
-31
-2% -$21.1K 0.21% 98
2026
Q1 		$1.12M Sell
1,444
-9
-0.6% -$6.89K 0.29% 88
2025
Q4 		$1.12M Sell
1,453
-25
-2% -$17K 0.29% 87
2025
Q3 		$831K Buy
1,478
+41
+3% +$23.2K 0.23% 90
2025
Q2 		$755K Buy
1,437
+14
+1% +$7.81K 0.27% 80
2025
Q1 		$903K Buy
1,423
+70
+5% +$48.1K 0.34% 73
2024
Q4 		$964K Sell
1,353
-2
-0.1% -$1.68K 0.36% 70
2024
Q3 		$1.42M Sell
1,355
-40
-3% -$44.5K 0.52% 60
2024
Q2 		$1.47M Hold
1,395
– – 0.57% 57
2024
Q1 		$1.34M Buy
1,395
+15
+1% +$14.3K 0.53% 62
2023
Q4 		$1.21M Buy
1,380
+100
+8% +$82.3K 0.53% 61
2023
Q3 		$1.05M Hold
1,280
– – 0.47% 66
2023
Q2 		$920K Sell
1,280
-35
-3% -$27K 0.41% 74
2023
Q1 		$1.08M Sell
1,315
-40
-3% -$30.2K 0.52% 63
2022
Q4 		$978K Hold
1,355
– – 0.47% 66
2022
Q3 		$933K Sell
1,355
-5
-0.4% -$3.15K 0.5% 66
2022
Q2 		$804K Hold
1,360
– – 0.4% 80
2022
Q1 		$950K Buy
1,360
+5
+0.4% +$3.16K 0.41% 74
2021
Q4 		$856K Buy
1,355
+5
+0.4% +$3.07K 0.35% 79
2021
Q3 		$817K Sell
1,350
-10
-0.7% -$6.21K 0.36% 80
2021
Q2 		$760K Buy
1,360
+81
+6% +$41K 0.33% 82
2021
Q1 		$605K Buy
1,279
+86
+7% +$41.9K 0.28% 87
2020
Q4 		$576K Buy
1,193
+105
+10% +$56.7K 0.29% 86
2020
Q3 		$609K Buy
1,088
+35
+3% +$21.2K 0.34% 84
2020
Q2 		$657K Buy
1,053
+60
+6% +$34.1K 0.39% 77
2020
Q1 		$485K Buy
993
+353
+55% +$146K 0.33% 82
2019
Q4 		$240K Buy
+640
New +$215K 0.09% 106

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Delta Financial Advisors's REGN Position: Q2 2026 in Review

Delta Financial Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 2.1% in Q2 2026, selling an estimated $21.1K and leaving 1,413 shares worth $881K. The position accounts for 0.21% of the portfolio, ranked #98.

Delta Financial Advisors first reported a position in REGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.47M in Q2 2024. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Delta Financial Advisors held 1,413 shares of Regeneron Pharmaceuticals worth $881K as of Q2 2026.
  • Delta Financial Advisors sold 31 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $21.1K.
  • Regeneron Pharmaceuticals made up 0.21% of Delta Financial Advisors's portfolio in Q2 2026, its #98 holding.
  • Delta Financial Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • Delta Financial Advisors's Regeneron Pharmaceuticals position peaked at $1.47M in Q2 2024.
  • 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Delta Financial Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.